For the Inventor, By the Inventor

Enter assignee name

Norwich, NY, United States of America

Norwich Eaton Pharmaceuticals, Inc.

USPTO Granted Patents = 47

CIPO Patents = 1

Trademarks = 5

Forward Citations = 489

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Stanford S Pelosi, Jr (10 out of 51 patents)

Chia-Nien Yu (5 out of 21 patents)

Ronald E White (5 out of 29 patents)

4. Frank Hallock Ebetino (4 out of 38 patents)

5. Robert J Alaimo (4 out of 17 patents)

6. Eugene G Drust (3 out of 3 patents)

7. George C Wright (3 out of 29 patents)

8. Allan V Bayless (3 out of 5 patents)

9. Chau-Ting Huang (2 out of 2 patents)

10. Ralph L White, Jr (2 out of 14 patents)

11. James J Benedict (2 out of 23 patents)

12. Michael J Kane (2 out of 3 patents)

13. Homer A Burch (2 out of 3 patents)

14. Kent W Buckingham (2 out of 3 patents)

15. Jocelyn E McOsker (2 out of 4 patents)

Core Competencies:

Antiarrhythmic Agents

Antimicrobial Compounds

Neuroprotective Agents

Transdermal Delivery

Cardiotonic Agents

Immunomodulating Agents

Lipid-Altering Agents

Sustained Release Capsules

Pharmaceutical Compositions

Diphosphonate Compounds

Aromatic Compounds

Medical Devices

47 patents: Sort by Forward Citations

1. 5462940 - 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents (1995-10-31),

2. 5273973 - Antimicrobial quinolonyl esters (1993-12-28),

3. 5260073 - Use of phenylpropanolamine as a mucus secretogogue in the upper airways (1993-11-09),

4. 5214042 - Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective (1993-05-25),

5. 5180719 - Antimicrobial quinolonyl lactam esters (1993-01-19),

6. 5178880 - Liquid suspensions of nitrofurantoin (1993-01-12),

7. 5137880 - Bicyclic diphosphonate compounds, pharmaceutical compositions, and (1992-08-11),

8. 5118708 - Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective (1992-06-02),

9. 5091426 - 5-phenyl-2-furan ketones and use as antiepileptic agents (1992-02-25),

10. 5071840 - Certain heterocyclic substituted diphosphonate compounds pharmaceutical (1991-12-10),

11. 5032406 - Dual-action tablet (1991-07-16),

12. 5026556 - Compositions for the transdermal delivery of pharmaceutical actives (1991-06-25),

13. 5023272 - Use of 5-phenyl-2-furan esters and amides as antiepileptic agents (1991-06-11),

14. 4982006 - Process for the preparation of certain substituted aromatic compounds (1991-01-01),

15. 4963681 - Process for synthesis of aminomethylene phosphonoalkylphosphinates (1990-10-16),

Norwich Eaton Pharmaceuticals, Inc. is a renowned pharmaceutical company specializing in the research, development, and manufacturing of innovative healthcare solutions. With a focus on delivering high-quality, cost-effective medications, we strive to improve the lives and well-being of individuals worldwide. Our commitment to excellence, advanced technology, and strong partnerships enable us to deliver cutting-edge pharmaceutical products that meet the evolving needs of patients and healthcare professionals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

47 Patents

#2 in Norwich, NY

#414 in New York

#7,193 in US

#14,414 in the World

Norwich, NY, United States of America

Norwich Eaton Pharmaceuticals, Inc.

Forward Citations = 489

47 inventors:

Stanford S Pelosi, Jr (10 out of 51 patents)

Chia-Nien Yu (5 out of 21 patents)

Ronald E White (5 out of 29 patents)

4. Frank Hallock Ebetino (4 out of 38 patents)

5. Robert J Alaimo (4 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…